(Q39210501)

10 September 2017

1 reference

title

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence (English)

1 reference

10 September 2017

0 references

0 references

2

R N Brogden

1 reference

10 September 2017

J P Gonzalez

1

1 reference

PubMed ID

2836152

10 September 2017

language of work or name

1 reference

1 March 1988

1 reference

10 September 2017

1 reference

10 September 2017

35

1 reference

10 September 2017

192-213

1 reference

10 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198835030-00002

10 September 2017

0 references

cites work

Naloxone treatment of opiate dependence. A progress report

1 reference

12 December 2020

Isolation and identification of a new metabolite of naltrexone in human blood and urine

1 reference

12 December 2020

Cold water stress analgesia in rats: differential effects of naltrexone

1 reference

12 December 2020

Naltrexone treatment of heroin addiction: one-year follow-up.

1 reference

12 December 2020

A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts

1 reference

12 December 2020

On the Role off Chemotherapy in the Treatment of Heroin Addiction

1 reference

12 December 2020

Clinical experience with naltrexone in suburban opioid addicts.

1 reference

12 December 2020

Naltrexone antagonizes the biobehavioral adaptation to cold water stress in rats.

1 reference

12 December 2020

Naltrexone and cyclazocine. A controlled treatment study

1 reference

12 December 2020

Successful use of naltrexone in addicted physicians and business executives.

1 reference

12 December 2020

Hormonal and Other Effects of Naltrexone in Normal Men

1 reference

12 December 2020

Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment

1 reference

12 December 2020

The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit

1 reference

12 December 2020

Naltrexone reverses bulimic symptoms

1 reference

12 December 2020

Discriminative stimulus effects of naltrexone in the morphine-dependent rat

1 reference

12 December 2020

Possible withdrawal from endogeneous opiates in schizophrenics

1 reference

12 December 2020

Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts

1 reference

12 December 2020

Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience.

1 reference

12 December 2020

Effects of heroin and naltrexone on plasma prolactin levels in man.

1 reference

12 December 2020

Disposition of narcotics and narcotic antagonists

1 reference

12 December 2020

Psychotherapy and naltrexone in opioid dependence

1 reference

12 December 2020

Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease

1 reference

12 December 2020

Drug discrimination studies

1 reference

12 December 2020

The identification and measurement of two new metabolites of naltrexone in human urine.

1 reference

12 December 2020

The effects of opiate receptor agonists and antagonists on the stress-induced secretion of corticosterone in mice

1 reference

12 December 2020

Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet

1 reference

12 December 2020

Naltrexone: its clinical utility.

1 reference

12 December 2020

Tritiated naltrexone binding in plasma from several species and tissue distribution in mice

1 reference

12 December 2020

Nontolerance to the opioid antagonism of naltrexone

1 reference

12 December 2020

Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity

1 reference

12 December 2020

New and experimental therapeutic roles for naloxone and related opioid antagonists

1 reference

12 December 2020

The treatment of narcotic withdrawal: a historical review.

1 reference

12 December 2020

Mixed agonist-antagonist opiates and physical dependence

1 reference

12 December 2020

Short-term effects of naltrexone in 155 heroin ex-addicts

1 reference

12 December 2020

A controlled trial of naltrexone in obese humans

1 reference

12 December 2020

Pharmacological advances in addiction treatment

1 reference

12 December 2020

Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.

1 reference

12 December 2020

The theoretical basis of narcotic addiction treatment with narcotic antagonists

1 reference

12 December 2020

Naltrexone effects on morphine and food self-administration in morphine-dependent rhesus monkeys.

1 reference

12 December 2020

Action of naloxone and naltrexone in different types of psychoses

1 reference

12 December 2020

The urinary excretion profile of naltrexone and metabolites in man

1 reference

12 December 2020

Assessment of naltrexone in the treatment of schizophrenia

1 reference

12 December 2020

Naltrexone, opiate addiction, and endorphins

1 reference

12 December 2020

Effect of naltrexone on senile dementia of the Alzheimer type

1 reference

12 December 2020

Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions

1 reference

12 December 2020

Repeated administration of naltrexone and diprenorphine decreases food intake and body weight in squirrel monkeys.

1 reference

12 December 2020

Continuous intravenous naltrexone effects on morphine self-administration in rhesus monkeys

1 reference

12 December 2020

The effects of naltrexone on the development of physical dependence on morphine

1 reference

12 December 2020

Naltrexone-induced dysphoria in former opioid addicts

1 reference

12 December 2020

Physiologic and morphologic changes and incidence of neoplasms in mice and rats fed naltrexone HCl for 24 months.

1 reference

12 December 2020

Heroin addiction. Sequential treatment employing pharmacologic supports

1 reference

12 December 2020

Treatment of heroin-dependent persons with antagonists: current status

1 reference

12 December 2020

Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists

1 reference

12 December 2020

The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone)

1 reference

12 December 2020

The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat

1 reference

12 December 2020

Effects of naltrexone on mood and neuroendocrine function in normal adult males

1 reference

12 December 2020

Opiate Antagonists and the Modification of Heroin Self-Administration Behavior in Man: An Experimental Study

1 reference

12 December 2020

Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration

1 reference

12 December 2020

On the specificity of naloxone as an opiate antagonist

1 reference

12 December 2020

The treatment of heroin addiction: naltrexone alone and with behavior therapy.

1 reference

12 December 2020

Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.

1 reference

12 December 2020

Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men.

1 reference

12 December 2020

Craving in heroin addicts maintained on the opiate antagonist naltrexone

1 reference

12 December 2020

Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers.

1 reference

12 December 2020

Aversive effects of naltrexone in subjects not dependent on opiates.

1 reference

12 December 2020

Quantitative determination of 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN), naltrexone, and 6 beta-naltrexol in human plasma, red blood cells, saliva, and urine by gas liquid chromatography

1 reference

12 December 2020

Operant analysis of human heroin self-administration and the effects of naltrexone.

1 reference

12 December 2020

Estimation of the systemic availability and other pharmacokinetic parameters of naltrexone in man after acute and chronic oral administration

1 reference

12 December 2020

Narcotic antagonist treatment: clinical experience with naltrexone

1 reference

12 December 2020

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

12 December 2020

The role of naltrexone in the management of drug abuse.

1 reference

12 December 2020

Effects of long-term therapy with naltrexone on body weight in obesity.

1 reference

12 December 2020

Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.

1 reference

12 December 2020

Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare

1 reference

12 December 2020

An oral opiate antagonist in chronic schizophrenia: a pilot study

1 reference

12 December 2020

Clinical pharmacokinetics of narcotic agonist-antagonist drugs

1 reference

12 December 2020

Methadone and naltrexone in the treatment of heroin dependence.

1 reference

12 December 2020

Clinical Experience with Naltrexone

1 reference

12 December 2020

Prevention of late fentanyl-induced respiratory depression after the injection of opiate antagonists naltrexone and S-20682: comparison with naloxone

1 reference

12 December 2020

Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison

1 reference

12 December 2020

Naloxone and naltrexone in mental illness and tardive dyskinesia.

1 reference

12 December 2020

Determination of 6-beta-naltrexol and naltrexone by bonded-phase adsorption thin-layer chromatography

1 reference

12 December 2020

Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.

1 reference

12 December 2020

Multiple family therapy and naltrexone in the treatment of opiate dependence

1 reference

12 December 2020

Heroin and naltrexone effects on pituitary-gonadal hormones in man: interaction of steroid feedback effects, tolerance and supersensitivity

1 reference

12 December 2020

Metabolism and disposition of naltrexone in man after oral and intravenous administration

1 reference

12 December 2020

Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist

1 reference

12 December 2020

Naloxone, naltrexone, and related noroxymorphones

1 reference

12 December 2020

Chronic naltrexone increases opiate binding in brain and produces supersensitivity to morphine in the locus coeruleus of the rat.

1 reference

12 December 2020

Naltrexone treatment of opiate-dependent persons

1 reference

12 December 2020

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

1 reference

12 December 2020

Effect of naltrexone on mood and cognitive functioning among overweight men.

1 reference

12 December 2020

Effect of an Opiate Antagonist on Movement Disorders

1 reference

12 December 2020

Naltrexone: a clinical perspective

1 reference

12 December 2020

Naltrexone: physiological and psychological effects of single doses.

1 reference

12 December 2020

Naltrexone and Alzheimer's disease.

1 reference

12 December 2020

10.2165/00003495-198835030-00002

Identifiers

DOI

1 reference

PubMed ID

2836152

Dimensions Publication ID

10 September 2017

0 references

1 reference

PubMed ID

2836152